Clinical Trial Update: Optimizing Metformin Use in Polycystic Ovary Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update aims to optimize metformin use for Polycystic Ovary Syndrome and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Polycystic Ovary Syndrome (PCOS) | Phase 3 | Status: NOT_YET_RECRUITING